百晓学者学者目录

刘晨源

清华大学经济管理学院经济系

个人简介

刘晨源,清华大学经济管理学院经济系副教授。研究领域为健康经济学、实证产业组织、保险经济学和应用微观经济学。讲授计量经济学(本科)、健康经济学(本科)和中国经济政策分析(博士)课程。教育背景为香港大学经济学学士(2015年)和美国威斯康星大学风险管理与保险博士(2020年)。

精选作品

期刊论文

  1. Chenyuan Liu, Yi Lu, Wanyu Yang (2026). Excessive Pharmaceutical Marketing Expenditure: Policy Remedies from China. The Review of Economics and Statistics.DOI
  2. Lan Zou, Chenyuan Liu (2026). Little Learning, Large Inertia: Deductible Choice in Swiss Health Insurance. Social Science Research Network.DOI
  3. Hong-Lin Li, Chenyuan Liu, Justin R. Sydnor (2025). Community Rating and Vertical Price Distortions in Insurance Menus. Social Science Research Network.DOI
  4. Chenyuan Liu, Yueyuan Ma, Binzhen Wu (2023). Information Disclosure and Marriage Quality: Evidence from Premarital Medical Exams. Social Science Research Network.DOI
  5. Chenyuan Liu, Justin Sydnor (2022). Dominated Options in Health Insurance Plans. American Economic Journal-Economic Policy, Vol. 14, No. 1.DOI
  6. Yu Ding, Chenyuan Liu (2021). Alternative payment models and physician treatment decisions: Evidence from lower back pain. Journal Of Health Economics, Vol. 800.DOI
  7. Chenyuan Liu (2019). Sorting on Plan Designs: Theory and Evidence from the ACA.
  8. Chenyuan Liu, Justin R. Sydnor (2017). How Common are Dominated Health Plan Options? Evidence from Employer Health Benefits with High-Deductible Plans.DOI
  9. 邢科,刘晨源(2014). 浅谈通货膨胀目标制的有效性. 《金融理论与实践》.

预印本

  1. Honglin Li, Chenyuan Liu, Justin Sydnor (2026). Is Choice Overload a Problem for Health-Plan Choice? Evidence from the ACA Marketplace. SSRN Electronic Journal.DOI
  2. Chenyuan Liu, Jiacheng Liu, Li Wei, Yi Yao (2026). The Downside of More: Choice Overload in Health Insurance Markets. SSRN Electronic Journal.DOI
  3. Chenyuan Liu, Yi Lu, Ronghe Sun, Wanyu Yang (2026). Expected Insurance Coverage and Pharmaceutical Innovation: Evidence from China's National Drug Price Negotiation Policy. SSRN Electronic Journal.DOI
  4. Chenyuan Liu, Haiting Tian, Wanyu Yang (2026). Decentralized Policy-making and Market Distortions: Evidence from China's Drug Formulary Design. SSRN Electronic Journal.DOI

研究方向

此主页由公开资料整理,尚未经学者本人认领。